Unbreakable
Bluelighter
- Joined
- Oct 22, 2009
- Messages
- 5,415
A cannabis-based pain-relief spray backed by Tom Lynch, the pharmaceutical veteran, received a regulatory high last week by being recommended for approval in 10 more European countries, including Ireland.
GW Pharmaceuticals, the AIM-listed developer of the new treatment called Sativex, already sells the product in Britain, Spain, Germany and Denmark, and hopes to launch it here this year. Justin Gover, managing director of GW said the only obstacle remaining to selling the spray in Ireland was for it to be added to the controlled drug schedule which will allow it be prescribed by doctors here.
“We’ll launch the product,” he said, “as soon as this is completed.”
Sativex is not addictive and has no withdrawal symptoms, and users experience no cannabis-like effects.
Source:Read more at the link but you sure gotta love news like this
http://www.independent.ie/business/...-drug-nears-approval-for-ireland-3105713.html
GW Pharmaceuticals, the AIM-listed developer of the new treatment called Sativex, already sells the product in Britain, Spain, Germany and Denmark, and hopes to launch it here this year. Justin Gover, managing director of GW said the only obstacle remaining to selling the spray in Ireland was for it to be added to the controlled drug schedule which will allow it be prescribed by doctors here.
“We’ll launch the product,” he said, “as soon as this is completed.”
Sativex is not addictive and has no withdrawal symptoms, and users experience no cannabis-like effects.
Source:Read more at the link but you sure gotta love news like this
http://www.independent.ie/business/...-drug-nears-approval-for-ireland-3105713.html